Technical Comparison
Ultragenyx Pharmaceutical Inc. - Common Stock vs NVIDIA Corporation - Common Stock
Real-time financial comparison matrix between RARE and NVDA.
Primary Asset
RAR
Ultragenyx Pharmaceutical Inc. - Common Stock
Market Rank #1004073Live Price$17.42
Market Capitalization$1.7B
24h Change+1.29%
Circulating Supply99M RARE
Comparison Asset
NVD
NVIDIA Corporation - Common Stock
Market Rank #101Live Price$213.87
Market Capitalization$5.2T
24h Change-0.70%
Circulating Supply24B NVDA
Market Metric Matrix
| Comparison Metric | RARE Value | NVDA Value | Dominant Asset |
|---|---|---|---|
| Market Cap Rank | #1004073 | #101 | NVIDIA Corporation - Common Stock |
| Unit Price Valuation | $17.42 | $213.87 | NVIDIA Corporation - Common Stock |
| Total Liquid Cap | $1.7B | $5.2T | NVIDIA Corporation - Common Stock |
Frequently Asked Questions
Is Ultragenyx Pharmaceutical Inc. - Common Stock bigger than NVIDIA Corporation - Common Stock?
Ultragenyx Pharmaceutical Inc. - Common Stock has a market cap of $1.7B, while NVIDIA Corporation - Common Stock sits at $5.2T. Therefore, NVIDIA Corporation - Common Stock is currently the larger financial asset by market capitalization.
What is the price ratio between Ultragenyx Pharmaceutical Inc. - Common Stock and NVIDIA Corporation - Common Stock?
Currently, 1 RARE is worth 0.08 NVDA.